Key terms

About CGC

Canopy Growth Corp. engages in the production, distribution, and sale of cannabis and cannabinoid-based products for both adult-use and medical purposes. The firm operates through the following segments: Canada Cannabis, Rest-of-world Cannabis, Storz and Bickel, BioSteel, This Works, and Other. The Canada Cannabis segment includes the production, distribution, and sale of cannabis, hemp, and cannabis products in Canada. The Rest-of-world Cannabis segment focuses on production and sale of cannabis, hemp, and cannabis products internationally. The Storz and Bickel segment produces and sells vaporizers. The BioSteel segment refers to the sale of consumer packaged goods including sports nutrition beverages, hydration mixes, proteins, and other specialty nutrition products. The This Works segment includes the production and sale of beauty, skincare, wellness, and sleep products, some of which have been blended with hemp-derived CBD isolate. The company was founded by Bruce Linton on August 5, 2009 and is headquartered in Smith Falls, Canada.

Sector
Industry
Employees
Founded
Website
Key stock statistics
1-day range
     
52-week range
     
Market cap
P/E ratio
Next earnings date
Dividend yield
Ex-dividend date
Dividend pay date

Key terms

Smart score

Latest CGC news

Today 7:50am ET Acreage Holdings provides update on corporate transactions Nov 22 8:45am ET Largest borrow rate increases among liquid names Nov 21 11:05am ET Rising High: Numinus Wellness to sell five Utah clinics for $3.53M Nov 20 8:20am ET Canopy Growth Expands with Claybourne Pre-Rolls in Canada Nov 20 7:41am ET Canopy Growth to launch California grown Claybourne brand in Canada Nov 18 8:45am ET Largest borrow rate increases among liquid names Nov 15 8:45am ET Largest borrow rate increases among liquid names Nov 14 12:30pm ET Rising High: Cannabis firms report quarterly earnings Nov 14 8:45am ET Largest borrow rate increases among liquid names Nov 13 8:45am ET Largest borrow rate increases among liquid names Nov 11 6:18am ET Canopy Growth Faces Ongoing Challenges and Limited Upside: Lewandowski Issues Sell Rating Nov 08 11:24pm ET Canopy Growth Reports Mixed Q2 FY2025 Results Nov 08 7:15am ET Canopy Growth reports Q2 EPS (C$1.48) vs. (C$4.33) last year Nov 08 7:05am ET Options Volatility and Implied Earnings Moves Today, November 08, 2024 Nov 07 11:25am ET Rising High: Exclusive talk with house of brands Carma HoldCo Nov 04 11:25am ET Canopy Growth call volume above normal and directionally bullish Nov 04 8:45am ET Largest borrow rate increases among liquid names Nov 04 7:00am ET Options Volatility and Implied Earnings Moves This Week, November 04 – November 08, 2024 Oct 31 10:30am ET Rising High: Compass Pathways reports Q3 earnings Oct 29 10:30am ET Canopy Growth call volume above normal and directionally bullish Oct 25 1:10pm ET Canopy Growth call volume above normal and directionally bullish Oct 25 8:45am ET Largest borrow rate increases among liquid names Oct 25 8:10am ET Canopy Growth Announces Q2 Fiscal 2025 Results Oct 24 10:30am ET Rising High: RIV Capital provides update on revenue, synergy realization Oct 23 8:45am ET Largest borrow rate increases among liquid names Oct 22 3:50pm ET Kansas, Utah voters support marijuana legalization, Marijuana Moment says Oct 22 12:45pm ET Canopy Growth call volume above normal and directionally bullish Oct 17 11:05am ET Rising High: Exclusive talk with vape tech developer Ispire Technology Oct 10 10:05am ET Rising High: Exclusive talk with cannabis REIT NewLake Capital Oct 09 8:09am ET Canopy Growth Expands U.S. Market Leadership with Wana Acquisition Oct 09 7:35am ET Canopy USA completes acquisition of Wana

CGC Financials

1-year income & revenue

Key terms

CGC Forecasts

analyst rating

  • buy
  • hold
  • sell

We're sorry, but this
information is
temporarily unavailable.

1-year stock price forecast

CGC Competitors

$ Market cap P/E ratio $ Price 1d change 52-week range

Key terms